Local infusion of the (±)-α-amino-3-hydroxy-5-methylisoxazole-4- propionate/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione does not block D1 dopamine receptor-mediated increases in immediate early gene expression in the dopamine-depleted striatum

Neuroscience

Volumn 89, Issue 2, 1999, Pages 491-504

  Keefe, K A ^a,b   Gerfen, C R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

C fos; Glutamate; In situ hybridization; SKF 38393; Tetrodotoxin; Zif268

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; DOPAMINE 1 RECEPTOR; TETRODOTOXIN; AMINO ACID RECEPTOR BLOCKING AGENT; AMPA RECEPTOR; DOPAMINE; KAINIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; DATA ANALYSIS; DOPAMINE BRAIN LEVEL; GENE EXPRESSION; IMMEDIATE EARLY GENE; IN SITU HYBRIDIZATION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; ANIMAL; CORPUS STRIATUM; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; MALE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; CORPUS STRIATUM; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION; GENES, IMMEDIATE-EARLY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, DOPAMINE D1; RECEPTORS, KAINIC ACID;

EID: 0033084214     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00327-3     Document Type: Article

References (66)

1. 1. Abercrombie E. D., Keefe K. A., DiFrischia D. S. and Zigmond M. J. (1989) Differential effects of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 52, 1655-1658.
2. 2. Aronin N., Chase K., Sagar S. M., Sharp F. R. and DiFiglia M. (1991) N-Methyl-D-aspartate receptor activation in the neostriatum increases c-fos and fos-related antigens selectively in medium-sized neurons. Neuroscience 44, 409-420.
3. 3. Bernard V., Dumartin B., Lamy E. and Bloch B. (1993) Fos immunoreactivity after stimulation or inhibition of muscarinic receptors indicates anatomical specificity for cholinergic control of striatal efferent neurons and cortical neurons in the rat. Eur. J. Neurosci. 5, 1218-1225.
4. 4. Bernard V., Normand E. and Bloch B. (1992) Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J. Neurosci. 12, 3591-3600.
5. 5. Berretta S., Robertson H. A. and Graybiel A. M. (1992) Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J. Neurophysiol. 68, 767-777.
6. 6. Boegman R. and Vincent S. (1996) Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol. Synapse 22, 70-77.
7. 7. Calabresi P., Mercuri N., Stanzione P., Stefani A. and Bernardi G. (1987) Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: Evidence for D1 receptor involvement. Neuroscience 20, 757-771.
8. 8. Cenci M. A. and Björklund A. (1993) Transection of corticostriatal afferents reduces amphetamine- and apomorphine-induced striatal fos expression and turning behavior in 6-hydroxydopamine-lesioned rats. Eur. J. Neurosci. 5, 1062-1070.
9. 9. Cenci M. A., Campbell K., Wictorin K. and Bjorklund A. (1992) Striatal c-fos induction by cocaine or apomorphine occurs preferentially in output neurons projecting to the substantia nigra in the rat. Eur. J. Neurosci. 4, 376-380.
10. 10. Cepeda C., Buchwald N. A. and Levine M. S. (1993) Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc. natn. Acad. Sci. U.S.A. 90, 9576-9580.
11. 11. Cherubini E., Herrling P. L., Lanfumey L. and Stanzione P. (1988) Excitatory amino acids in synaptic excitation of rat striatal neurons in vitro. J. Physiol. 400, 677-690.
12. 12. Cherubini E. and Lanfumey L. (1987) An inward calcium current underlying regenerative calcium potentials in rat striatal neurons in vitro enhanced by Bay K 8644. Neuroscience 21, 997-1005.
13. 13. Church W. H., Justice J. B. Jr and Neill D. B. (1987) Detecting behaviorally relevant changes in extracellular dopamine with microdialysis. Brain Res. 412, 397-399.
14. 14. Curran T., Gordon M. B., Rubino K. L. and Sambucetti L. C. (1987) Isolation and characterization of the c-fos (rat) cDNA and analysis of post-translational modification in vitro. Oncogene 2, 79-84.
15. 15. Di Chiara G., Morelli M. and Consolo S. (1994) Modulatory functions of neurotransmitters in the striatum: Ach/dopamine/NMDA interactions. Trends Neurosci. 17, 228-233.
16. 2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons. Neuroscience 37, 287-294.
17. 17. Enslen H. and Soderling T. R. (1994) Roles of calmodulin-dependent protein kinases and phosphatase in calcium-dependent transcription of immediate early genes. J. biol. Chem. 269, 20,872-20,877.
18. 18. Freund T. F., Powell J. F. and Smith A. D. (1984) Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience 13, 1189-1215.
19. 19. Fu L. and Beckstead R. M. (1992) Cortical stimulation induces FOS expression in striatal neurons. Neuroscience 46, 329-334.
20. 20. Gerfen C. R., Engber T. M., Mahan L. C., Susel Z., Chase T. N., Monsma F. J. Jr and Sibley D. R. (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429- 1432.
21. 21. Gerfen C. R., Keefe K. A. and Gauda E. B. (1995) D1 and D2 dopamine receptor function in the striatum: co-activation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J. Neurosci. 15, 8167-8176.
22. 22. Gerfen C. R. and Young W. S. (1988) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460, 161-167.
23. 23. Ginty D. D., Kornhauser J. M., Thompson M. A., Bading H., Mayo K. E., Takahashi J. S. and Greenberg M. E. (1993) Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and circadian clock. Science 260, 238-241.
24. 24. Gonzalez G. A. and Montminy M. R. (1989) Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59, 675-680.
25. 25. Haber S. N. and Nauta W. J. (1983) Ramifications of the globus pallidus in the rat as indicated by patterns of immunohistochemistry. Neuroscience 9, 245-260.
26. 26. Herrling P. L. (1985) Pharmacology of the corticocaudate excitatory postsynaptic potential in the cat: evidence for its mediation by quisqualate- or kainate-receptors. Neuroscience 14, 417-426.
27. 27. Hersch S., Ciliax B., Gutekunst C.-A., Rees H., Heilman C., Yung K., Bolam J. P., Ince E., Yi H. and Levey A. (1995) Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J. Neurosci. 15, 5222-5237.
28. 28. Jiang Z.-G. and North R. A. (1991) Membrane properties and synaptic responses of rat striatal neurones in vitro. J. Physiol. 443, 533-553.
29. 29. Kawaguchi Y., Wilson C. J. and Emson P. C. (1990) Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J. Neurosci. 10, 3421-3438.
30. 30. Keefe K. A. and Gerfen C. R. (1995) D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience 66, 903-913.
31. 31. Keefe K. A. and Gerfen C. R. (1996) D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors. J. Comp. Neurol. 367, 165-176.
32. 32. Kemp J. M. and Powell T. P. (1971) The termination of fibres from the cerebral cortex and thalamus upon dendritic spines in the caudate nucleus: a study with the Golgi method. Phil. Trans. R. Soc. Lond. B, Biol. Sci. 262, 429-439.
33. 33. Kita H., Kita T. and Kitai S. T. (1985) Regenerative potentials in rat neostriatal neurons in an in vitro slice preparation. Expl Brain Res. 60, 63-70.
34. 34. Kitai S. T., Kocsis J. D. and Wood J. (1976) Origin and characteristics of the cortico-caudate afferents: an anatomical and electrophysiological study. Brain Res. 118, 137-141.
35. 35. Kitai S. T. and Surmeier D. J. (1993) Cholinergic and dopaminergic modulatio of potassium conductances in neostriatal neurons. In Advances in Neurology (eds Narabayashi H., Nagatsu T., Yanagisawa N. and Mizuno Y.), pp. 40-52. Raven, New York.
36. 36. Konradi C., Cole R. L., Heckers S. and Hyman S. E. (1994) Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J. Neurosci. 14, 5623-5634.
37. 37. Konradi C., Leveque J.-C. and Hyman S. E. (1996) Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on post-synaptic NMDA receptors and calcium. J. Neurosci. 16, 4231-4239.
38. 38. Labandeira-Garcia J. L. and Guerra M. J. (1994) Cortical stimulation induces fos expression in intrastriatal striatal grafts. Brain Res. 652, 87-97.
39. 39. Le Moine C. and Bloch B. (1995) D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mrnas in distinct neuronal populations of the dorsal and ventral striatum. J. comp. Neurol. 355, 418-426.
40. 40. Le Moine C., Normand E. and Bloch B. (1991) Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc. natn. Acad. Sci. U.S.A. 88, 4205-4209.
41. 2 requiring intracellular signaling pathways. Soc. Neurosci. Abstr. 19, 23.
42. 42. McGeer P. L., McGeer E. G., Scherer U. and Singh K. (1977) A glutamatergic corticostriatal path? Brain Res. 128, 369-373.
43. 43. Milbrandt J. (1987) A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 238, 797-799.
44. 44. Moghaddam B. (1993) Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J. Neurochem. 60, 1650-1657.
45. 45. Morari M., O'Connor W., Darvelid M., Ungerstedt U., Bianchi C. and Fuxe K. (1996) Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat - I. Effects of perfusion with tetrodotoxin and low-calcium medium. Neuroscience 72, 79-87.
46. 46. Morari M., O'Connor W. T., Ungerstedt U. and Fuxe K. (1993) N-Methyl-D-aspartic acid differentially regulates extracellular dopamine, GABA, and glutamate levels in the dorsolateral neostriatum of the halothane-anesthetized rat: an in vivo microdialysis study. J. Neurochem. 60, 1884-1893.
47. 47. O'Connor W. T., Tanganelli S., Ungerstedt U. and Fuxe K. (1992) The effects of neurotensin on GABA and acetylcholine release in the dorsal striatum of the rat: an in vivo microdialysis study. Brain Res. 573, 209-216.
48. 48. Osborne P. G., O'Connor W. T., Drew K. L. and Ungerstedt U. (1990) An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake freely moving and halothane anaesthetised rats. J. Neurosci. Meth. 34, 99-105.
49. 49. Page K. J. and Everitt B. J. (1993) Transsynaptic induction of c-fos in basal forebrain, diencephalic and midbrain neurons following AMPA-induced activation of the dorsal and ventral striatum. Expl Brain Res. 93, 399-411.
50. 50. Paul M. L., Graybiel A. M., David J.-C. and Robertson H. A. (1992) D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12, 3729-3742.
51. 1 dopamine receptor-activated c-fos. Brain Res. 523, 288-290.
52. 1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behavior. Brain Res. 503, 346-349.
53. 53. Robinson T. E. and Whishaw I. Q. (1988) Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res. 450, 209-224.
54. 54. Ruskin D. N. and Marshall J. F. (1994) Amphetamine- and cocaine-induced fos in the rat striatum depends on D2 dopamine receptor activation. Synapse 18, 233-240.
55. 55. Snyder-Keller A. M. (1991) Striatal C-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: importance of NMDA activation and relevance to sensitization phenomena. Expl Neurol. 113, 155-165.
56. 56. Vincent S. R., Hökfelt T., Christensson I. and Terenius L. (1982) Immunohistochemical evidence for a dynorphin immunoreactive striatonigral pathway. Eur. J. Pharmac. 85, 251-252.
57. 57. Wang J., Smith A. and McGinty J. (1995) A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif268, and preprodynporphin mRNA expression in rat forebrain. Neuroscience 68, 83-95.
58. 58. Wang J. Q., Daunais J. B. and McGinty J. F. (1994) NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse 18, 343-353.
59. 59. Wang J. Q., Daunais J. B. and McGinty J. F. (1994) Role of kainate/AMPA receptors in induction of striatal zif/268 and preprodynorphin mRNA by a single injection of amphetamine. Brain Res. Molec. Brain Res. 27, 118-126.
60. 60. Wang J. Q. and McGinty J. F. (1996) Glutamatergic and cholinergic regulation of immediate-early gene and neuropeptide gene expression in the striatum. In Pharmacological Regulation of Gene Expression in the CNS (ed. Merchant K.), pp. 81-113. CRC, New York.
61. 61. Westerink B. H. C., Damsma G., Rollema H., De Vries J. B. and Horn A. S. (1987) Scope and limitations of in vivo brain dialysis: a comparison of its application to various neurotransmitter systems. Life Sci. 41, 1763-1776.
62. 62. Westerink B. H. C., Tuntler J., Damsma G., Rollema H. and De Vries J. B. (1987) The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. Naunyn-Schmiedeberg's Arch. Pharmac. 336, 502-507.
63. 63. Wirtshafter D. and Asin K. E. (1994) Interactive effects of stimulation of D1 and D2 dopamine receptors on fos-like immunoreactivity in the normosensitive rat striatum. Brain Res. Bull. 35, 85-91.
64. 64. Worley P. F., Bhat R. V., Baraban J. M., Erickson C. A., McNaughton B. L. and Barnes C. A. (1993) Thresholds for synaptic activation of transcription factors in hippocampus: correlation with long-term enhancement. J. Neurosci. 13, 4776-4786.
65. 65. Yamamoto K. K., Gonzalez G. A., Biggs W. H. I. and Montminy M. R. (1988) Phosphorylation-induced binding and transcriptional efficiency of nuclear factor CREB. Nature 334, 494-498.
66. 66. Ziolkowska B. and Hollt V. (1993) The NMDA receptor antagonist MK-801 markedly reduces the induction of c-fos gene by haloperidol in the mouse striatum. Neurosci. Lett. 156, 39-42.